Clinical trial
RxSight Light Adjustable Lens (LAL) And Light Delivery Device (LDD) New Enrollment Study
NCT05202808 is registered in ClinicalTrials.gov with RxSight, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- RxSight Light Adjustable Lens (LAL) And Light Delivery Device (LDD) New Enrollment Study
- Lead sponsor
- RxSight, Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 3, 2021
- Completion date
- December 16, 2024
- Enrollment
- 500 (actual)
- Sites
- 14
Conditions
As the registry lists them; a condition with its own page is linked.